noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Healthcare

BrightFocus Foundation

Exploring How Glaucoma Affects Mood and Sleep Problems
Lisa Murkowski

Senator Murkowski presents Chief Reverend Dr. Trimble Gilbert with[...]
DOH - South Dakota Department of[...]

Secretary Melissa Magstadt Recognizes the State Public Health[...]

Eli Lilly and Company

06/04/2022 | Press release | Distributed by Public on 06/04/2022 08:15

Lilly's SURMOUNT-1 results published in The New England Journal of Medicine show tirzepatide achieved between 16.0% and 22.5% weight loss in adults with obesity or overweight

Sharing and Personal Tools

Please select the service you want to use:

Smartlinks | Eli Lilly and Company | News | Health | Local News | Company News | Business Announcement | Products and Services | New Products | Public Companies | Pharmaceutical Companies | London Stock Exchange (LSE) | New York Stock Exchange (NYSE) | Börse Frankfurt | Six Swiss Exchange | Bolsa de Valores de São Paulo (B3) | Wiener Börse (ATX) | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | Bolsa Mexicana de Valores (BMV) | Bolsa de Comercio de Buenos Aires (BCBA) | BX Swiss | Tradegate Exchange | XETRA | NYSE American | NYSE ARCA Equities | Turquoise | Börse Hamburg | Börse Hannover | BZX Exchange | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | Nasdaq Intermarket | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | EuroTLX | Proveedor Integral de Precios (PIP) | NYSE Chicago | Bolsa Institucional de Valores (BIVA)

Back

Download the original document